sodium oxybate 4500 MG Granules for Oral Suspension
RxNorm concept 2636822, clinical drug (scd). Prescribable name: sodium oxybate 4.5 GM Granules for extended release Oral Suspension.
- RxCUI
- 2636822
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2636822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
sodium oxybate 4.5 GM (equivalent to 3.7 GM oxybate) Granules for Oral Suspension
Related concepts
- sodium oxybate 4500 MG (SCDC, consists of)
- {7 (sodium oxybate 4500 MG Granules for Oral Suspension) / 14 (sodium oxybate 6000 MG Granules for Oral Suspension) / 7 (sodium oxybate 7500 MG Granules for Oral Suspension) } Pack (GPCK, contained in)
- Granules for Oral Suspension (DF, has dose form)
- sodium oxybate 4500 MG Granules for Oral Suspension [Lumryz] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2636822 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2636822 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2636822. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.